<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="bhd" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">bhd</book-part-id>
      <title-group>
        <title>Birt-Hogg-Dub&#x000e9; Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Toro</surname>
            <given-names>Jorge R</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Genetic Epidemiology Branch<break/>Division of Cancer Epidemiology and Genetics<break/>National Cancer Institute<break/>National Institutes of Health<break/>Bethesda, Maryland</aff>
          <email>toroj@mail.nih.gov</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>27</day>
          <month>2</month>
          <year>2006</year>
        </date>
        <date date-type="updated">
          <day>7</day>
          <month>8</month>
          <year>2014</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="bgd-biotin" document-type="chapter">Biotin-Thiamine-Responsive Basal Ganglia Disease</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="bpes" document-type="chapter">Blepharophimosis, Ptosis, and Epicanthus Inversus</related-object>
      <abstract id="bhd.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>The clinical characteristics of Birt-Hogg-Dub&#x000e9; syndrome (BHDS) include cutaneous manifestations (fibrofolliculomas, trichodiscomas/angiofibromas, perifollicular fibromas, and acrochordons), pulmonary cysts/history of pneumothorax, and various types of renal tumors. Disease severity can vary significantly even within the same family. Skin lesions typically appear during the third and fourth decades of life and typically increase in size and number with age. Lung cysts are mostly bilateral and multifocal; most individuals are asymptomatic but at high risk for spontaneous pneumothorax. Individuals with BHDS are at a sevenfold increased risk for renal tumors that are typically bilateral and multifocal and usually slow growing; median age of tumor diagnosis is 48 years. The most common renal tumors are a hybrid of oncocytoma and chromophobe histologic cell types (so-called oncocytic hybrid tumor) and chromophobe histologic cell types. Some families have renal tumor and/or autosomal dominant spontaneous pneumothorax without cutaneous manifestations.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>BHDS is diagnosed by clinical findings and by molecular genetic testing. <italic toggle="yes">FLCN</italic> (also known as <italic toggle="yes">BHD</italic>) is the only gene known to be associated with BHDS. Sequence analysis detects pathogenic variants in <italic toggle="yes">FLCN</italic> in 88% of affected families, whereas 3%-5% have partial- or whole-gene deletions identified by other methods. Therefore, approximately 7%-9% of affected individuals who fulfill clinical diagnostic criteria do not have an identifiable <italic toggle="yes">FLCN</italic> pathogenic variant.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Laser ablation of folliculoma/trichodiscoma results in substantial improvement for a period of time, but relapse usually occurs. Pneumothoraces are treated as in the general population. When possible, nephron-sparing surgery is the treatment of choice for renal tumors, depending on their size and location.</p>
          <p><italic toggle="yes">Surveillance:</italic> Periodic MRI of the kidneys is the optimal screening modality to assess for kidney lesions; abdominal/pelvic CT scan with contrast is an alternative when MRI is not an option, but the long term effects of cumulative radiation exposure is unknown; full body skin examination at routine intervals to evaluate for melanoma should be considered.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Cigarette smoking, high ambient pressures, and radiation.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> Molecular genetic testing for the family-specific pathogenic variant for early identification of at-risk family members improves diagnostic certainty and reduces costly screening procedures in at-risk relatives who have not inherited the family-specific pathogenic variant.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>BHDS is inherited in an autosomal dominant manner. The offspring of an individual with BHDS have a 50% chance of inheriting the pathogenic variant. Prenatal diagnosis for pregnancies at increased risk is possible if the <italic toggle="yes">FLCN</italic> pathogenic variant of an affected family member has been identified.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="bhd.Diagnosis">
        <title>Diagnosis</title>
        <sec id="bhd.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>Three major features characterize Birt-Hogg-Dub&#x000e9; syndrome (BHDS):</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Cutaneous manifestations.</bold> Individuals with BHDS usually present with multiple, small, skin-colored, dome-shaped papules distributed over the face, neck, and upper trunk. The original characteristic dermatologic triad was fibrofolliculomas, trichodiscomas, and acrochordons [<xref ref-type="bibr" rid="bhd.REF.toro.1999.1195">Toro et al 1999</xref>]; however, only fibrofolliculomas are specific for BHDS. Perifollicular fibromas and angiofibromas have also been associated with BHDS. Trichodiscomas are essentially histologically and clinically indistinguishable from angiofibromas; the term trichodiscoma has been used to describe angiofibromas when they occur in the setting of BHDS.</p>
              <p>The dermatologic diagnosis of BHDS is made in individuals who have five or more facial or truncal papules with at least one histologically confirmed fibrofolliculoma [<xref ref-type="bibr" rid="bhd.REF.toro.1999.1195">Toro et al 1999</xref>]:</p>
              <list list-type="bullet">
                <list-item>
                  <p><bold>Fibrofolliculomas</bold> are defined as multiple anastomosing strands of two to four epithelial cells extending from a central follicle. Sometimes a well-demarcated, mucin-rich, or thick connective tissue stroma encapsulates the epithelial component. Biopsy is required to make the diagnosis.</p>
                  <p>Note: Shave biopsy is usually not adequate. More than one skin-punch biopsy and sectioning of the paraffin-embeded block is sometimes needed to make the diagnosis of fibrofolliculoma.</p>
                </list-item>
                <list-item>
                  <p><bold>Trichodiscomas</bold> are hamartomatous lesions comprising a round to elliptically shaped well-demarcated proliferation of thick fibrous and vascular stroma in the reticular dermis with a hair follicle at the periphery. Because of the high density of hair follicles in the face, hair follicles are commonly found at the periphery of these lesions. <bold>Angiofibromas</bold> are clinically and histologically essentially the same as trichodiscomas.</p>
                  <p>Note: Trichodiscomas/angiofibromas are suggestive for the diagnosis of BHDS but not diagnostic. Angiofibromas are commonly also found in <related-object link-type="booklink" source-id="gene" document-id="tuberous-sclerosis" document-type="chapter">tuberous sclerosis complex</related-object> (TSC) and <related-object link-type="booklink" source-id="gene" document-id="men1" document-type="chapter">multiple endocrine neoplasia type 1</related-object> (MEN1).</p>
                </list-item>
                <list-item>
                  <p><bold>Acrochordons,</bold> or skin tags, are soft pedunculated papules that histologically are characterized by acanthotic and mild papillomatous epidermis with loose connective tissue stroma and blood vessels.</p>
                </list-item>
                <list-item>
                  <p><bold>Perifollicular fibromas</bold> are well-demarcated proliferations of fibrous and vascular stroma in the reticular dermis surrounding a hair follicle.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Lung cysts and spontaneous pneumothorax.</bold> Most individuals (89%) with BHDS have multiple bilateral lung cysts, identified by high-resolution chest CT. The total number of lung cysts per individual ranges from 0 to 166 (mean 16). Forty-eight (24%) of 198 individuals with BHDS had a history of one or more pneumothoraces [<xref ref-type="bibr" rid="bhd.REF.toro.2007.1044">Toro et al 2007</xref>].</p>
              <list list-type="bullet">
                <list-item>
                  <p>All individuals with a history of pneumothorax had multiple lung cysts identified by high-resolution chest CT imaging. BHDS-related lung cysts abutted on interlobular septa (88.2%) and had intracystic septa (13.6%) or protruding venules (39.5%) without cell proliferation or inflammation. BHDS-related lung cysts are likely to develop in the periacina region where alveoli attach to connective tissue [<xref ref-type="bibr" rid="bhd.REF.kumasaka.2014.100">Kumasaka et al 2014</xref>].</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Renal tumors.</bold> The renal tumors are usually bilateral and multifocal. Histologic tumor types include: hybrid oncocytic renal cell carcinoma, oncocytoma, chromophobe renal cell carcinoma, and a minority of clear cell renal cell carcinoma. Note: <italic toggle="yes">FLCN</italic> nucleotide variants have been identified in certain tumors, see Molecular Genetics, <xref ref-type="sec" rid="bhd.Cancer_and_Benign_Tumors">Cancer and Benign Tumors</xref>.</p>
            </list-item>
          </list>
          <p>Note: The original description and diagnosis of BHDS is based on skin pathology. However, recent investigations have shown that some individuals with BHDS could present with pulmonary involvement and/or renal tumors without skin lesions.</p>
        </sec>
        <sec id="bhd.Molecular_Genetic_Testing">
          <title>Molecular Genetic Testing</title>
          <p><bold>Gene.</bold>
<italic toggle="yes">FLCN</italic> is the only gene in which pathogenic variants are known to cause BHDS.</p>
          <p>
            <bold>Clinical testing</bold>
          </p>
          <table-wrap id="bhd.T.summary_of_molecular_genetic_testi" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Birt-Hogg-Dub&#x000e9; Syndrome</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_bhd.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_bhd.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_bhd.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant Detectable by This Method&#x000a0;<sup>2</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_bhd.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">FLCN</italic>
                  </td>
                  <td headers="hd_h_bhd.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis of exon 11&#x000a0;<sup>3,&#x000a0;4</sup></td>
                  <td headers="hd_h_bhd.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~53%&#x000a0;<sup>5</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_bhd.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Sequence analysis of entire coding region&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_bhd.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~88%</td>
                </tr>
                <tr>
                  <td headers="hd_h_bhd.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_bhd.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~3%-5%</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="bhd.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="bhd" object-id="bhd.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="bhd.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="bhd.TF.1.2">
                <label>2. </label>
                <p><xref ref-type="bibr" rid="bhd.REF.schmidt.2005.1023">Schmidt et al [2005]</xref>, <xref ref-type="bibr" rid="bhd.REF.toro.2008.321">Toro et al [2008]</xref></p>
              </fn>
              <fn id="bhd.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="bhd.TF.1.4">
                <label>4. </label>
                <p>Pathogenic variants detected: Polycytosine tract deletion (<xref ref-type="table" rid="bhd.T.flcn_pathogenic_variants_discussed">c.1285delC</xref>) / duplication (<xref ref-type="table" rid="bhd.T.flcn_pathogenic_variants_discussed">c.1285dupC</xref>)</p>
              </fn>
              <fn id="bhd.TF.1.5">
                <label>5. </label>
                <p>Twenty-seven (53%) of 51 families with BHDS were found to have deletion (<xref ref-type="table" rid="bhd.T.flcn_pathogenic_variants_discussed">c.1285delC</xref>) or duplication (<xref ref-type="table" rid="bhd.T.flcn_pathogenic_variants_discussed">c.1285dupC</xref>) of a C nucleotide in the polycytosine tract in exon 11, which is a mutational hot spot (see <xref ref-type="table" rid="bhd.T.flcn_pathogenic_variants_discussed">Table 2</xref>).</p>
              </fn>
              <fn id="bhd.TF.1.6">
                <label>6. </label>
                <p>Testing that identifies exon or whole-gene deletions/duplications not detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="bhd.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>To confirm/establish the diagnosis in a proband.</bold> Molecular genetic testing is indicated in all individuals known to have or suspected of having BHDS, including individuals with one of the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Five or more facial or truncal papules with at least one histologically confirmed fibrofolliculoma [<xref ref-type="bibr" rid="bhd.REF.toro.1999.1195">Toro et al 1999</xref>], with or without a family history of BHDS</p>
            </list-item>
            <list-item>
              <p>Facial papules histologically confirmed to be angiofibroma in an individual who does not fit the clinical criteria of <related-object link-type="booklink" source-id="gene" document-id="tuberous-sclerosis" document-type="chapter">tuberous sclerosis complex</related-object> (TSC) or <related-object link-type="booklink" source-id="gene" document-id="men1" document-type="chapter">multiple endocrine neoplasia type 1</related-object> (MEN1)</p>
            </list-item>
            <list-item>
              <p>Multiple and bilateral chromophobe, oncocytic, and/or hybrid renal tumors</p>
            </list-item>
            <list-item>
              <p>A single oncocytic, chromophobe, or oncocytic hybrid renal tumor and a family history of renal cancer with any of the above renal cell tumor types</p>
            </list-item>
            <list-item>
              <p>A family history of autosomal dominant primary spontaneous pneumothorax without a history of smoking or COPD</p>
            </list-item>
          </list>
          <p><bold>Single-gene testing.</bold> One strategy for molecular diagnosis of a proband suspected of having BHDS is cascade testing of <italic toggle="yes">FLCN</italic>:</p>
          <list list-type="order">
            <list-item>
              <label>1</label>
              <p>Molecular genetic testing may start with sequence analysis of exon 11, as a majority of affected individuals have one of two pathogenic variants found in exon 11 (see <xref ref-type="table" rid="bhd.T.summary_of_molecular_genetic_testi">Table 1</xref>).</p>
            </list-item>
            <list-item>
              <label>2</label>
              <p>If targeted sequence analysis of exon 11 does not identify a pathogenic variant, sequencing of the entire coding region of <italic toggle="yes">FLCN</italic> should be considered.</p>
            </list-item>
            <list-item>
              <label>3</label>
              <p>If full-gene sequence analysis does not identify a pathogenic variant, deletion/duplication analysis of <italic toggle="yes">FLCN</italic> may be considered.</p>
            </list-item>
          </list>
          <p><bold>Multi-gene panel.</bold> Another strategy for molecular diagnosis of a proband suspected of having BHDS is a multi-gene panel that includes genes known to cause various features of the condition (see <xref ref-type="sec" rid="bhd.Differential_Diagnosis">Differential Diagnosis</xref>). These panels vary by methods used and genes included; thus, the ability of a panel to detect a causative allelic variant in any given individual with features of BHDS also varies. For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
          <p><bold>Exome sequencing.</bold> In individuals with a clinical diagnosis of BHDS but in whom no pathogenic variant in <italic toggle="yes">FLCN</italic> is identified, exome sequencing may be considered.</p>
        </sec>
      </sec>
      <sec id="bhd.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="bhd.Clinical_Description">
          <title>Clinical Description</title>
          <p>The clinical characteristics of Birt-Hogg-Dub&#x000e9; syndrome (BHDS) include fibrofolliculomas (specific cutaneous lesions), pulmonary cysts/history of pneumothorax, and various types of renal tumors. Disease severity can vary significantly among family members and between families.</p>
          <p><bold>Cutaneous lesions.</bold> BHDS is associated with a spectrum of cutaneous hamartomas ranging from angiofibroma to perifollicular fibromas to fibrofolliculomas [<xref ref-type="bibr" rid="bhd.REF.toro.2008.321">Toro et al 2008</xref>]. Families with germline pathogenic variants in <italic toggle="yes">FLCN</italic> can have angiofibromas (i.e., trichodiscomas), perifollicular fibroma, or both angiofibroma and perifollicular fibromas as their only cutaneous manifestations of BHDS [<xref ref-type="bibr" rid="bhd.REF.toro.2008.321">Toro et al 2008</xref>]. Other individuals with BHDS develop oral papules and cutaneous collagenomas [<xref ref-type="bibr" rid="bhd.REF.nadershahi.1997.496">Nadershahi et al 1997</xref>, <xref ref-type="bibr" rid="bhd.REF.toro.1999.1195">Toro et al 1999</xref>]. Multiple epidermal cysts have been found in approximately 14% of individuals with BHDS [<xref ref-type="bibr" rid="bhd.REF.kluger.2010.527">Kluger et al 2010</xref>].</p>
          <p>The onset of skin lesions is typically during the third or fourth decade of life. Skin lesions tend to increase in size and number with age. Later onset of cutaneous lesions tends to correlate with a milder skin phenotype. Women tend to have smaller and fewer lesions than men.</p>
          <p>BHDS has been reported to be associated with cutaneous melanoma, including multiple desmoplastic melanomas [<xref ref-type="bibr" rid="bhd.REF.lindor.2001.653">Lindor et al 2001</xref>, <xref ref-type="bibr" rid="bhd.REF.khoo.2002.906">Khoo et al 2002</xref>, <xref ref-type="bibr" rid="bhd.REF.welsch.2005.668">Welsch et al 2005</xref>, <xref ref-type="bibr" rid="bhd.REF.toro.2008.321">Toro et al 2008</xref>, <xref ref-type="bibr" rid="bhd.REF.sempau.2010.637">Sempau et al 2010</xref>, <xref ref-type="bibr" rid="bhd.REF.cocciolone.2010.1316">Cocciolone et al 2010</xref>, <xref ref-type="bibr" rid="bhd.REF.motaburgos.2013.323">Mota-Burgos et al 2013</xref>] and choroidal melanoma [<xref ref-type="bibr" rid="bhd.REF.fontcuberta.2011.143">Fontcuberta et al 2011</xref>]. Whether individuals with BHDS are at increased risk of developing melanoma compared to the general population requires further investigation.</p>
          <p>A family with BHDS in which one sib developed a dermatofibrosarcoma protuberans (DFSP) and another sib had a cutaneous leiomyosarcoma has also been described [<xref ref-type="bibr" rid="bhd.REF.toro.2008.321">Toro et al 2008</xref>].</p>
          <p><bold>Pulmonary cysts and spontaneous pneumothorax.</bold> Lung cysts are mostly bilateral and multifocal. Most individuals with BHDS and lung cysts are asymptomatic, but they have a high risk of developing spontaneous, often recurrent, pneumothorax. Clinical presentation of pneumothorax ranges from asymptomatic to dyspnea and chest pain. Clinical findings include tachypnea or decreased or absent breath sounds. Radiographic investigation may require a high-resolution CT of the chest to confirm the diagnosis of pneumothorax as chest x-ray may not be sensitive enough to detect a loculated pneumothorax.</p>
          <p>In the recent study of <xref ref-type="bibr" rid="bhd.REF.toro.2008.321">Toro et al [2008]</xref>, 89% of individuals with a <italic toggle="yes">FLCN</italic> germline pathogenic variant were found to have pulmonary cysts on chest CT, a rate that is higher than the 77% observed in all earlier reports combined.</p>
          <p>In the same study of <xref ref-type="bibr" rid="bhd.REF.toro.2008.321">Toro et al [2008]</xref>, 38% of individuals with a <italic toggle="yes">FLCN</italic> germline pathogenic variant were found to have a history of spontaneous pneumothorax, a rate similar to the 33% in all earlier reports combined.</p>
          <p>Individuals with BHDS and a family history of pneumothorax have a statistically significant increased risk of pneumothorax compared to individuals with BHDS without a family history of spontaneous pneumothorax.</p>
          <p>Individuals with BHDS have a 50-fold increased risk for spontaneous pneumothorax compared to family members who do not have BHDS [<xref ref-type="bibr" rid="bhd.REF.zbar.2002.393">Zbar et al 2002</xref>].</p>
          <p><bold>Renal cysts and tumors.</bold> In a French case series, renal ultrasound, CT scan and/or MRI revealed renal cysts in ten (45%) of 22 individuals with BHDS who did not have renal carcinoma diagnosed at the time of screening [<xref ref-type="bibr" rid="bhd.REF.kluger.2010.527">Kluger et al 2010</xref>].</p>
          <p>Approximately 70 individuals with <italic toggle="yes">FLCN</italic> germline pathogenic variant and kidney tumors have been reported [<xref ref-type="bibr" rid="bhd.REF.toro.2008.321">Toro et al 2008</xref>]. The most common tumors are a hybrid of oncocytoma and chromophobe histologic cell types, so-called oncocytic hybrid tumor (67%), chromophobe renal cell carcinoma (23%), and renal oncocytoma (3%). Only renal oncocytoma is considered a benign tumor [<xref ref-type="bibr" rid="bhd.REF.pavlovich.2005.1482">Pavlovich et al 2005</xref>]. Other types of renal tumors reported in lower frequency include clear cell renal cell carcinoma and papillary renal carcinoma.</p>
          <p>Most renal tumors associated with BHDS are bilateral, multifocal, and slow growing. Median age of diagnosis is 48 years, with a range from 31 to 71 years [<xref ref-type="bibr" rid="bhd.REF.schmidt.2005.1023">Schmidt et al 2005</xref>].</p>
          <p>Individuals with BHDS were at a sevenfold increased risk for renal tumors compared with their unaffected sibs [<xref ref-type="bibr" rid="bhd.REF.zbar.2002.393">Zbar et al 2002</xref>]. Using combined ascertainment in dermatologic and urologic oncology clinics at the National Cancer Institute (NCI) at the National Institutes of Health (NIH), the overall prevalence of kidney tumors among individuals with germline <italic toggle="yes">FLCN</italic> pathogenic variants was 29%-34% [<xref ref-type="bibr" rid="bhd.REF.toro.2008.321">Toro et al 2008</xref>]. This high frequency &#x02013; compared to the 6.5% frequency of kidney tumors in BHDS cases determined from a combination of other investigators &#x02013; may reflect ascertainment bias.</p>
          <p>The renal tumors associated with BHDS may affect morbidity more than mortality in persons with BHDS. Nephron-sparing surgery may decrease the morbidity associated with renal tumors by preserving functioning renal tissue because affected individuals usually develop multifocal and bilateral kidney tumors.</p>
          <p>Renal oncocytosis observed at surgery or at postmortem examination is evidence of the potential of persons with BHDS to develop kidney tumors [<xref ref-type="bibr" rid="bhd.REF.toro.2008.321">Toro et al 2008</xref>].</p>
          <p><bold>Parotid oncocytoma.</bold> The first case of an individual with BHDS who developed a parotid oncocytoma was reported in 2000 [<xref ref-type="bibr" rid="bhd.REF.liu.2000.1120">Liu et al 2000</xref>]. Subsequently multiple cases have been reported [<xref ref-type="bibr" rid="bhd.REF.schmidt.2005.1023">Schmidt et al 2005</xref>, <xref ref-type="bibr" rid="bhd.REF.toro.2008.321">Toro et al 2008</xref>]. Additionally, one person with BHDS has been reported with a pleomorphic adenoma [<xref ref-type="bibr" rid="bhd.REF.palmirotta.2008.382">Palmirotta et al 2008</xref>] and another individual with BHDS has been reported with a Warthin parotid tumor [<xref ref-type="bibr" rid="bhd.REF.maff_.2011.345">Maff&#x000e9; et al 2011</xref>]. Two cases of bilateral parotid tumors have also been reported [<xref ref-type="bibr" rid="bhd.REF.maff_.2011.345">Maff&#x000e9; et al 2011</xref>, <xref ref-type="bibr" rid="bhd.REF.lindor.2012.13">Lindor et al 2012</xref>]. The frequency and the bilateral, multifocal nature of these tumors in individuals with BHDS who have not undergone specific screening for parotid tumors suggest that parotid tumors are a manifestation of BHDS.</p>
          <p><bold>Oral papules</bold> have been reported in nine (43%) of 21 individuals with BHDS in a large French case series [<xref ref-type="bibr" rid="bhd.REF.kluger.2010.527">Kluger et al 2010</xref>] and in several other reports [<xref ref-type="bibr" rid="bhd.REF.nadershahi.1997.496">Nadershahi et al 1997</xref>, <xref ref-type="bibr" rid="bhd.REF.toro.1999.1195">Toro et al 1999</xref>].</p>
          <p>
            <bold>Other findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Thyroid pathology.</bold> Three cases of thyroid cancer in affected individuals have been reported [<xref ref-type="bibr" rid="bhd.REF.toro.2008.321">Toro et al 2008</xref>, <xref ref-type="bibr" rid="bhd.REF.kunogi.2010.281">Kunogi et al 2010</xref>]. Multinodular goiter [<xref ref-type="bibr" rid="bhd.REF.drummond.2002.301">Drummond et al 2002</xref>, <xref ref-type="bibr" rid="bhd.REF.welsch.2005.668">Welsch et al 2005</xref>] and thyroid nodules and/or cysts have also been reported. In a French case series, thyroid nodules and/or cysts were detected by ultrasonography in 13 (65%) of 20 individuals with BHDS; no medullary carcinoma or other thyroid carcinomas were detected. None of the affected individuals with thyroid nodules and/or cysts had a familial history of thyroid cancer. Overall, nine (90%) of ten families affected by BHDS with germline pathogenic variants in <italic toggle="yes">FLCN</italic> had individuals with thyroid nodules [<xref ref-type="bibr" rid="bhd.REF.kluger.2010.527">Kluger et al 2010</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Colon cancer.</bold> Multiple cases of colon cancer have been described in affected individuals [<xref ref-type="bibr" rid="bhd.REF.toro.2008.321">Toro et al 2008</xref>], but the evidence associating colonic neoplasm and BHDS is conflicting [<xref ref-type="bibr" rid="bhd.REF.khoo.2002.906">Khoo et al 2002</xref>, <xref ref-type="bibr" rid="bhd.REF.zbar.2002.393">Zbar et al 2002</xref>] (see <xref ref-type="sec" rid="bhd.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref> and <xref ref-type="sec" rid="bhd.Molecular_Genetics">Molecular Genetics</xref>).</p>
            </list-item>
            <list-item>
              <p><bold>Other tumor types</bold> have been reported rarely in individuals with BHDS:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Squamous cell carcinoma of the head and neck [<xref ref-type="bibr" rid="bhd.REF.toro.2008.321">Toro et al 2008</xref>]</p>
                </list-item>
                <list-item>
                  <p>Hodgkin disease [<xref ref-type="bibr" rid="bhd.REF.toro.2008.321">Toro et al 2008</xref>]</p>
                </list-item>
                <list-item>
                  <p>Uterine cancer [<xref ref-type="bibr" rid="bhd.REF.toro.2008.321">Toro et al 2008</xref>]</p>
                </list-item>
                <list-item>
                  <p>Prostate cancer [<xref ref-type="bibr" rid="bhd.REF.toro.2008.321">Toro et al 2008</xref>]</p>
                </list-item>
                <list-item>
                  <p>Breast cancer [<xref ref-type="bibr" rid="bhd.REF.toro.2008.321">Toro et al 2008</xref>, <xref ref-type="bibr" rid="bhd.REF.kunogi.2010.281">Kunogi et al 2010</xref>]</p>
                </list-item>
                <list-item>
                  <p>Squamous cell carcinoma of the cervix [<xref ref-type="bibr" rid="bhd.REF.toro.2008.321">Toro et al 2008</xref>]</p>
                </list-item>
                <list-item>
                  <p>Rhabdomyoma [<xref ref-type="bibr" rid="bhd.REF.toro.2008.321">Toro et al 2008</xref>]</p>
                </list-item>
                <list-item>
                  <p>An adrenal mass and adenoma of adrenal gland [<xref ref-type="bibr" rid="bhd.REF.toro.2008.321">Toro et al 2008</xref>, <xref ref-type="bibr" rid="bhd.REF.kunogi.2010.281">Kunogi et al 2010</xref>]</p>
                </list-item>
                <list-item>
                  <p>Myoma of the uterus [<xref ref-type="bibr" rid="bhd.REF.kunogi.2010.281">Kunogi et al 2010</xref>]</p>
                </list-item>
                <list-item>
                  <p>Lipoma, angiolipoma, and collagenoma [<xref ref-type="bibr" rid="bhd.REF.toro.1999.1195">Toro et al 1999</xref>]</p>
                </list-item>
                <list-item>
                  <p>Cutaneous neural tumors: neurothekeoma (benign myxoma of cutaneous nerve sheath origin), meningioma [<xref ref-type="bibr" rid="bhd.REF.vincent.2003.717">Vincent et al 2003</xref>] and multiple neurilemmomas [<xref ref-type="bibr" rid="bhd.REF.renfree.2012.792">Renfree &#x00026; Lawless 2012</xref>]</p>
                </list-item>
                <list-item>
                  <p>Ovarian cyst [<xref ref-type="bibr" rid="bhd.REF.godbolt.2003.52">Godbolt et al 2003</xref>]</p>
                </list-item>
                <list-item>
                  <p>Parathyroid adenoma [<xref ref-type="bibr" rid="bhd.REF.chung.1996.365">Chung et al 1996</xref>]</p>
                </list-item>
                <list-item>
                  <p>Chorioretinal lesions [<xref ref-type="bibr" rid="bhd.REF.walter.1997.359">Walter et al 1997</xref>, <xref ref-type="bibr" rid="bhd.REF.godbolt.2003.52">Godbolt et al 2003</xref>]</p>
                </list-item>
                <list-item>
                  <p>Neuroendocrine carcinoma [<xref ref-type="bibr" rid="bhd.REF.claessens.2010.583">Claessens et al 2010</xref>]</p>
                </list-item>
              </list>
            </list-item>
          </list>
        </sec>
        <sec id="bhd.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Genotype-phenotype correlations have been reported; whether these manifestations are truly associated with BHDS remains to be determined through larger studies.</p>
          <p>No correlation is observed between the type of <italic toggle="yes">FLCN</italic> pathogenic variant and pulmonary and cutaneous manifestations.</p>
          <p>A previous study suggested that individuals with the <xref ref-type="table" rid="bhd.T.flcn_pathogenic_variants_discussed">c.1285delC</xref> pathogenic variant may be at lower risk of developing renal cancers than individuals with other <italic toggle="yes">FLCN</italic> pathogenic variants; this needs to be evaluated in large studies.</p>
          <p>Analysis of genotype-phenotype correlations for two recurrent <italic toggle="yes">FLCN</italic> pathogenic variants identified in a subset of 51 families with BHDS demonstrated a significantly higher risk of colorectal neoplasia in those with the <xref ref-type="table" rid="bhd.T.flcn_pathogenic_variants_discussed">c.1285dupC</xref> pathogenic variant (within the exon 11 C(8) mononucleotide tract) than in those with the <xref ref-type="table" rid="bhd.T.flcn_pathogenic_variants_discussed">c.610delGCinsTA</xref> pathogenic variant (chi(2)=5.78, p=0.016) [<xref ref-type="bibr" rid="bhd.REF.nahorski.2010.385">Nahorski et al 2010</xref>].</p>
        </sec>
        <sec id="bhd.Penetrance">
          <title>Penetrance</title>
          <p>Based on the three major clinical manifestations, penetrance of BHDS is considered to be very high.</p>
        </sec>
        <sec id="bhd.Anticipation">
          <title>Anticipation</title>
          <p>Anticipation is not known to occur in BHDS.</p>
        </sec>
        <sec id="bhd.Nomenclature">
          <title>Nomenclature</title>
          <p>Hornstein-Knickenberg syndrome (HK), which describes familial multiple perifollicular fibromas, is considered to fall within the spectrum of BHDS [<xref ref-type="bibr" rid="bhd.REF.schulz.1999.55">Schulz &#x00026; Hartschuh 1999</xref>].</p>
        </sec>
        <sec id="bhd.Prevalence">
          <title>Prevalence</title>
          <p>More than 100 affected families from various populations have been described.</p>
        </sec>
      </sec>
      <sec id="bhd.Genetically_Related_Allelic_Disorder">
        <title>Genetically Related (Allelic) Disorders</title>
        <p><bold>Autosomal dominant primary spontaneous pneumothorax.</bold> Germline pathogenic variants in <italic toggle="yes">FLCN</italic> were found in families with dominantly inherited spontaneous pneumothorax. Pulmonary involvement appears to be the only manifestation; penetrance is 100% [<xref ref-type="bibr" rid="bhd.REF.graham.2005.39">Graham et al 2005</xref>, <xref ref-type="bibr" rid="bhd.REF.painter.2005.522">Painter et al 2005</xref>].</p>
      </sec>
      <sec id="bhd.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><bold>Cutaneous lesions.</bold> Fibrofolliculomas are rare and specific for Birt-Hogg-Dub&#x000e9; syndrome (BHDS). Because fibrofolliculomas are clinically similar to various cutaneous lesions, histologic diagnosis is required.</p>
        <p>Acrochordons, or skin tags, are nonspecific and are found in the general population.</p>
        <p>BHDS-associated hamartomas should be distinguished from other genodermatoses with an increased risk for internal malignancy, including tuberous sclerosis complex (TSC), familial trichoepitheliomas, <related-object link-type="booklink" source-id="gene" document-id="men1" document-type="chapter">MEN1</related-object>, and Cowden syndrome (see <related-object link-type="booklink" source-id="gene" document-id="phts" document-type="chapter"><italic toggle="yes">PTEN</italic> Hamartoma Tumor Syndrome</related-object>).</p>
        <p><bold>Pulmonary manifestation.</bold> Several inherited and noninherited conditions can present with lung cysts and/or pneumothorax. A thorough history and physical examination help to differentiate these conditions from BHDS. These conditions include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="marfan" document-type="chapter">Marfan syndrome</related-object>
            </p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="eds4" document-type="chapter">Ehlers-Danlos syndrome, vascular type</related-object>
            </p>
          </list-item>
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="tuberous-sclerosis" document-type="chapter">Tuberous sclerosis complex</related-object>
            </p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="alpha1-a" document-type="chapter">Alpha1-antitrypsin deficiency</related-object> [<xref ref-type="bibr" rid="bhd.REF.daniel.2000.327">Daniel &#x00026; Teba 2000</xref>]</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="cf" document-type="chapter">Cystic fibrosis</related-object> [<xref ref-type="bibr" rid="bhd.REF.flume.2005.720">Flume et al 2005</xref>]</p>
          </list-item>
          <list-item>
            <p>Langerhan cell histiocytosis (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/604856">604856</ext-link>) [<xref ref-type="bibr" rid="bhd.REF.mendez.2004.1028">Mendez et al 2004</xref>]</p>
          </list-item>
          <list-item>
            <p>Pulmonary lymphangioleiomyomatosis (LAM) (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/606690">606690</ext-link>) occurring as an isolated finding or as part of TSC</p>
          </list-item>
        </list>
        <p><bold>Renal tumor.</bold> Unlike BHDS, most familial renal cancer syndromes are associated with different types of renal pathology [<xref ref-type="bibr" rid="bhd.REF.linehan.2005.2">Linehan et al 2005</xref>]. Familial renal cancer syndromes and their renal pathology include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="vhl" document-type="chapter">von Hippel-Lindau syndrome</related-object> (VHL syndrome). Bilateral and multifocal clear cell renal cell carcinomas. Individuals with VHL syndrome are also at risk for central nervous system hemangioblastoma, retinal angioma, pheochromocytoma, and endolymphatic sac tumors.</p>
          </list-item>
          <list-item>
            <p>Hereditary papillary renal cancer (HPRC). Bilateral and multifocal type 1 papillary renal cell carcinomas</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="hlrcc" document-type="chapter">Hereditary leiomyomatosis and renal cell cancer</related-object> (HLRCC). Usually solitary renal tumors with a histologic spectrum ranging from tubo-papillary renal cell cancer to type 2 papillary renal cancer to collecting duct renal cell cancer. Individuals with HLRCC can present with cutaneous leiomyoma and/or with early-onset and aggressive uterine fibroids.</p>
          </list-item>
        </list>
      </sec>
      <sec id="bhd.Management">
        <title>Management</title>
        <sec id="bhd.Evaluations_Following_Initial_Diagno">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with Birt-Hogg-Dub&#x000e9; syndrome (BHDS), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Detailed dermatologic examination and punch biopsy of suspected cutaneous lesion</p>
            </list-item>
            <list-item>
              <p>High-resolution computed tomography (HRCT) or CT of the chest highly recommended for visualization of pulmonary cysts. Individuals who have symptoms/signs of pneumothorax should immediately undergo chest x-ray and CT of the chest and appropriate treatment.</p>
            </list-item>
            <list-item>
              <p>Baseline abdominal/pelvic CT scan with contrast or MRI to screen for renal tumor. Renal ultrasound examination may distinguish cystic from solid renal lesions.</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="bhd.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>In general, fibrofolliculomas and trichodiscomas are benign lesions for which no treatment is required; however, affected individuals may seek treatment for such lesions for cosmetic purposes, particularly when multiple cutaneous lesions are located on the face. Treatment of fibrofolliculomas and trichodiscomas is difficult, as they tend to be numerous and recurring. Erbium-YAG or fractional CO<sub>2</sub> laser ablation may result in substantial improvement, but relapse can occur [<xref ref-type="bibr" rid="bhd.REF.gambichler.2000.856">Gambichler et al 2000</xref>, <xref ref-type="bibr" rid="bhd.REF.jacob.2001.98">Jacob &#x00026; Dover 2001</xref>, <xref ref-type="bibr" rid="bhd.REF.kahle.2001.43">Kahle et al 2001</xref>]. Shaving or other ablative methods have been used with variable results.</p>
          <p>Treatment of pneumothorax is the same as in the general population.</p>
          <p>Nephron-sparing surgery is the treatment of choice for renal tumors whenever possible, depending on the size and location of the tumors [<xref ref-type="bibr" rid="bhd.REF.pavlovich.2005.1482">Pavlovich et al 2005</xref>]. Because of the bilateral, multifocal nature of BHDS-associated kidney cancer, a management approach involving observation of small tumors until they reach 3 cm in size is often recommended [<xref ref-type="bibr" rid="bhd.REF.pavlovich.2005.1482">Pavlovich et al 2005</xref>]. Therefore, renal tumors greater than 3.0 cm and/or rapidly growing tumors usually require partial nephrectomy. When surgical intervention is recommended, an attempt is made to remove all or most of the visible tumors. Although surgical management is not considered &#x0201c;curative&#x0201d; for BHDS-associated renal cell carcinoma (RCC), BHDS-associated renal tumors often are slow growing, and only infrequently are multiple surgical procedures required during a an affected individual&#x02019;s lifetime to control the tumor burden and prevent the development of metastasis.</p>
        </sec>
        <sec id="bhd.Prevention_of_Primary_Manifestations">
          <title>Prevention of Primary Manifestations</title>
          <p>No preventive or curative treatment is available for BHDS. However, development of renal cell carcinoma has the strongest positive association with cigarette smoking [<xref ref-type="bibr" rid="bhd.REF.moore.2005.240">Moore et al 2005</xref>].</p>
        </sec>
        <sec id="bhd.Surveillance">
          <title>Surveillance</title>
          <p>There is no consensus on clinical surveillance; the recommendations given are provisional until a consensus conference is conducted.</p>
          <p>Individuals with known BHDS, individuals known to have a pathogenic variant in <italic toggle="yes">FLCN</italic> without clinical manifestations, and at-risk family members who have not undergone genetic testing should have regular monitoring by physicians familiar with the spectrum of BHDS.</p>
          <p>
            <bold>Renal tumor screening</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Renal imaging is appropriate for individuals age 18 years or older when the clinical diagnosis of BHDS is established or if a pathogenic variant in <italic toggle="yes">FLCN</italic> is confirmed. However, earlier testing and surveillance for renal tumors should be personalized based on family history of renal tumor development, when available.</p>
            </list-item>
            <list-item>
              <p>Yearly MRI of the kidneys is the optimal screening modality to assess for kidney lesions.</p>
              <list list-type="bullet">
                <list-item>
                  <p>Abdominal/pelvic CT scan with contrast is an alternative when MRI is not an option. However, the long-term effects of cumulative radiation exposure in individuals with BHDS is unknown and has not been studied.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>As a result of the low aggressiveness of kidney tumors and the 3.0-cm rule used by surgeons in treating renal tumors [<xref ref-type="bibr" rid="bhd.REF.pavlovich.2005.1482">Pavlovich et al 2005</xref>], affected individuals without a family history of kidney tumors who have had two to three consecutive annual MRI examinations without the detection of kidney lesions may be screened every two years until a suspicious lesion is identified.</p>
              <p>Note: The use of renal ultrasound examination is helpful in further characterization of kidney lesions but should not be used as a primary screening modality.</p>
            </list-item>
            <list-item>
              <p>If any suspicious lesion (&#x0003c;1.0 cm in diameter, indeterminate lesion, or complex cysts) is noted on screening examination, annual MRI should be instituted. Abdominal/pelvic CT scan with contrast may be used as an alternative in those for whom MRI is not an option.</p>
            </list-item>
            <list-item>
              <p>Renal tumors less than 3.0 cm in diameter are monitor by periodic imaging. When the largest renal tumor reaches 3 cm in maximal diameter evaluation by a urologic surgeon is appropriate with consideration of nephron-sparing surgery [<xref ref-type="bibr" rid="bhd.REF.stamatakis.2013.397">Stamatakis et al 2013</xref>].</p>
            </list-item>
            <list-item>
              <p>Rapidly growing lesions and/or symptoms including pain, blood in the urine, or atypical presentations require a more individualized approach. PET-CT scan is an option for evaluation of these lesions.</p>
            </list-item>
          </list>
          <p><bold>Melanoma.</bold> Because of a concern for a possible increased risk of melanoma in those with BHDS, full body skin examination at routine intervals to evaluate for suspicious pigmented lesions should be considered.</p>
        </sec>
        <sec id="bhd.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>The following should be avoided:</p>
          <list list-type="bullet">
            <list-item>
              <p>Cigarette smoking</p>
            </list-item>
            <list-item>
              <p>High ambient pressures, which may precipitate spontaneous pneumothorax</p>
            </list-item>
            <list-item>
              <p>Radiation exposure</p>
            </list-item>
          </list>
        </sec>
        <sec id="bhd.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>When the family-specific pathogenic variant is known, use of molecular genetic testing for early identification of at-risk family members improves diagnostic certainty and reduces costly screening procedures in at-risk members who have not inherited the pathogenic variant.</p>
          <p>Early recognition of clinical manifestations may allow timely intervention and improve outcome. Therefore, clinical surveillance of asymptomatic at-risk relatives for early detection is appropriate.</p>
          <p>See <xref ref-type="sec" rid="bhd.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="bhd.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="bhd.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="bhd.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Birt-Hogg-Dub&#x000e9; syndrome (BHDS) is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="bhd.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Some individuals with BHDS have an affected parent, and some have BHDS as a result of a <italic toggle="yes">de novo</italic> pathogenic variant in <italic toggle="yes">FLCN</italic>.</p>
            </list-item>
            <list-item>
              <p>The proportion of cases caused by a <italic toggle="yes">de novo</italic> pathogenic variant is unknown because a sufficient number of parents have not been evaluated for subtle manifestation, nor are there sufficient data on clinically unaffected parents who have been evaluated by molecular genetic testing.</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with a suspected <italic toggle="yes">de novo</italic>
<italic toggle="yes">FLCN</italic> pathogenic variant include molecular genetic testing if the variant in the proband is identified.</p>
            </list-item>
          </list>
          <p>Note: Although some individuals diagnosed with BHDS have an affected parent, the family history may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disease in the affected parent.</p>
          <p><bold>Sibs of a proband.</bold> The risk to the sibs of the proband depends on the genetic status of the proband's parents:</p>
          <list list-type="bullet">
            <list-item>
              <p>If a parent of a proband is clinically affected or has an <italic toggle="yes">FLCN</italic> pathogenic variant, the sibs of the proband are at a 50% risk of inheriting the pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>If neither parent has the <italic toggle="yes">FLCN</italic> pathogenic variant identified in the proband, the risk to sibs is low but greater than that of the general population because of the possibility of germline mosaicism.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with BHDS is at a 50% risk of inheriting the <italic toggle="yes">FLCN</italic> pathogenic variant. The degree of clinical severity is not predictable.</p>
          <p><bold>Other family members of a proband.</bold> The risk to other family members depends on the status of the proband's parents: if a parent is affected, his or her family members are at risk.</p>
        </sec>
        <sec id="bhd.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="bhd.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with BHDS has the <italic toggle="yes">FLCN</italic> pathogenic variant or clinical evidence of the disorder, it is likely that mutation of <italic toggle="yes">FLCN</italic> occurred <italic toggle="yes">de novo</italic> in the proband. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p><bold>Testing at-risk asymptomatic family members.</bold> Molecular genetic testing of at-risk family members is appropriate in order to identify the need for continued lifelong clinical surveillance. Interpretation of the result is most accurate when an <italic toggle="yes">FLCN</italic> pathogenic variant has been identified in an affected family member. Those who have the pathogenic variant require lifelong, regular surveillance. Family members who have not inherited the pathogenic variant and their offspring have risks similar to the general population.</p>
          <p>Early detection of at-risk individuals affects medical management. However, in the absence of an increased risk of developing childhood malignancy, the American Society of Clinical Oncology (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.asco.org/">ASCO</ext-link>) recommends delaying genetic testing in at-risk individuals until they reach age 18 years and are able to make informed decisions regarding genetic testing [<xref ref-type="bibr" rid="bhd.REF1">American Society of Clinical Oncology 2003</xref>] (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://jco.ascopubs.org/content/21/12/2397.full">full text</ext-link>).</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="bhd.Prenatal_Testing_and_Preimplantation">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">FLCN</italic> pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for BHDS are possible.</p>
        </sec>
      </sec>
      <sec id="bhd.Resources">
        <title>Resources</title>
      </sec>
      <sec id="bhd.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">FLCN</italic> (<italic toggle="yes">BHD</italic>) was identified by positional cloning by <xref ref-type="bibr" rid="bhd.REF.nickerson.2002.157">Nickerson et al [2002]</xref>. The gene is highly conserved across species. Human <italic toggle="yes">FLCN</italic> consists of 14 exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="bhd" object-id="bhd.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> See <xref ref-type="table" rid="bhd.T.flcn_pathogenic_variants_discussed">Table 2</xref>. Various pathogenic variants have been identified in families with Birt-Hogg-Dub&#x000e9; syndrome (BHDS). All pathogenic variants predict protein truncation. The most common pathogenic variants are c.1285dupC and c.1285delC, which duplicate or delete a single C nucleotide in a polycytosine tract in exon 11, suggesting the presence of a hypermutable site [<xref ref-type="bibr" rid="bhd.REF.schmidt.2005.1023">Schmidt et al 2005</xref>].</p>
        <table-wrap id="bhd.T.flcn_pathogenic_variants_discussed" orientation="portrait" position="anchor">
          <label>Table 2. </label>
          <caption>
            <p><italic toggle="yes">FLCN</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_bhd.T.flcn_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change (Alias&#x000a0;<sup>1</sup>)</th>
                <th id="hd_h_bhd.T.flcn_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_bhd.T.flcn_pathogenic_variants_discussed_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_bhd.T.flcn_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.610_611delGCinsTA</td>
                <td headers="hd_h_bhd.T.flcn_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ala204Ter</td>
                <td headers="hd_h_bhd.T.flcn_pathogenic_variants_discussed_1_1_1_3" rowspan="3" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_144997.4">NM_144997.4</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_659434.2">NP_659434.2</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_bhd.T.flcn_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1285dupC<break/>(1733insC)</td>
                <td headers="hd_h_bhd.T.flcn_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.His429ProfsTer26</td>
              </tr>
              <tr>
                <td headers="hd_h_bhd.T.flcn_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1285delC<break/>(1733delC)</td>
                <td headers="hd_h_bhd.T.flcn_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.His429ThrfsTer38</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the author. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn id="bhd.TF.2.1">
              <label>1. </label>
              <p>Variant designation that does not conform to current naming conventions</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>For more information, see <related-object source-id="gene" document-id="bhd" object-id="bhd.molgen.TA">Table A</related-object>.</p>
        <p><bold>Normal gene product.</bold> Folliculin (FLCN) has 579 amino acid residues. A role for folliculin is suggested in regulation of 5' AMP-activated protein kinase (AMPK) and activation of the mTOR signaling pathway. Specifically, folliculin forms a complex with folliculin interacting protein 1 or 2 (encoded by <italic toggle="yes">FNIP1</italic> or <italic toggle="yes">FNIP2</italic>) and the FLCN-FNIP complex binds to AMPK [<xref ref-type="bibr" rid="bhd.REF.baba.2006.15552">Baba et al 2006</xref>, <xref ref-type="bibr" rid="bhd.REF.hasumi.2008.60">Hasumi et al 2008</xref>, <xref ref-type="bibr" rid="bhd.REF.takagi.2008.5339">Takagi et al 2008</xref>]. Recent studies suggest that loss of FLCN expression leads to activation of the AMPK/PGC-1&#x003b1;/OXPHOS/HIF signaling axis [<xref ref-type="bibr" rid="bhd.REF.klomp.2010.59">Klomp et al 2010</xref>]. Loss of FLCN constitutively activates AMPK, resulting in PGC-1&#x003b1;-mediated mitochondrial biogenesis and increased ROS production [<xref ref-type="bibr" rid="bhd.REF.yan.2014.2640">Yan et al 2014</xref>]. It is hypothesized that FLCN inhibits tumorigenesis by preventing AMPK-dependent HIF activation and the subsequent Warburg metabolic transformation [<xref ref-type="bibr" rid="bhd.REF.yan.2014.2640">Yan et al 2014</xref>]. Loss of FLCN induces an AMPK-HIF-dependent metabolic reprogramming favoring tumor progression.</p>
        <p>FLCN is highly expressed in a variety of tissues including skin and skin appendages, type 1 pneumocytes, and distal nephrons of the kidney [<xref ref-type="bibr" rid="bhd.REF.warren.2004.998">Warren et al 2004</xref>].</p>
        <p><bold>Abnormal gene product.</bold> Germline pathogenic variants in <italic toggle="yes">FLCN</italic> &#x02013; as well as somatic variants and loss of heterozygosity in tumor tissue &#x02013; suggest that loss of function of the folliculin protein is the basis of tumor formation in BHDS [<xref ref-type="bibr" rid="bhd.REF.vocke.2005.931">Vocke et al 2005</xref>]. Reduced expression of folliculin in renal tumors from individuals with BHDS supports its role in tumor suppression [<xref ref-type="bibr" rid="bhd.REF.warren.2004.998">Warren et al 2004</xref>].</p>
        <sec id="bhd.Cancer_and_Benign_Tumors">
          <title>Cancer and Benign Tumors</title>
          <p>Acquired nucleotide variants in <italic toggle="yes">FLCN</italic> have been identified in sporadic clear cell renal cell carcinoma [<xref ref-type="bibr" rid="bhd.REF.da_silva.2003.820">da Silva et al 2003</xref>, <xref ref-type="bibr" rid="bhd.REF.khoo.2003.4583">Khoo et al 2003</xref>] and colon cancer [<xref ref-type="bibr" rid="bhd.REF.kahnoski.2003.511">Kahnoski et al 2003</xref>, <xref ref-type="bibr" rid="bhd.REF.shin.2003.364">Shin et al 2003</xref>], without other associated tumors characteristic of the heritable disease.</p>
          <list list-type="bullet">
            <list-item>
              <p><italic toggle="yes">FLCN</italic> pathogenic variants have been identified in two cell lines with MSI [<xref ref-type="bibr" rid="bhd.REF.shin.2003.364">Shin et al 2003</xref>].</p>
            </list-item>
            <list-item>
              <p>In one study, 16% of MSI sporadic colorectal carcinoma harbored pathogenic variants in the poly C8 track of <italic toggle="yes">FLCN</italic> [<xref ref-type="bibr" rid="bhd.REF.shin.2003.364">Shin et al 2003</xref>].</p>
            </list-item>
            <list-item>
              <p>An independent English study found that somatic frameshifting variants in the exon 11 C(8) mononucleotide tract of <italic toggle="yes">FLCN</italic> were detected in 23% of sporadic colorectal cancers with microsatellite instability [<xref ref-type="bibr" rid="bhd.REF.nahorski.2010.385">Nahorski et al 2010</xref>].</p>
            </list-item>
            <list-item>
              <p>Two heterozygous <italic toggle="yes">FLCN</italic> missense variants have been reported in colorectal cancer cell lines.</p>
            </list-item>
          </list>
          <p>Further studies are needed to investigate the role of folliculin in colorectal carcinogenesis.</p>
        </sec>
        <sec id="bhd.Molecular_Pathogenesis">
          <title>Molecular Pathogenesis</title>
          <p>BHDS-associated renal tumors have distinct gene expression and cytogenetic characteristics as compared to sporadic renal oncocytoma and chromophobe RCC [<xref ref-type="bibr" rid="bhd.REF.klomp.2010.59">Klomp et al 2010</xref>]. BHDS-derived kidney tumors have high expression of mitochondria- and oxidative phosphorylation-associated genes and deregulation of the PGC-1&#x003b1;-TFAM signaling axis. In addition, loss of <italic toggle="yes">FLCN</italic> expression is also associated with increased nuclear mitochondrial gene expression [<xref ref-type="bibr" rid="bhd.REF.klomp.2010.59">Klomp et al 2010</xref>].</p>
        </sec>
      </sec>
      <sec id="bhd.References">
        <title>References</title>
        <sec id="bhd.Published_GuidelinesConsensus_Statem">
          <title>Published Guidelines/Consensus Statements</title>
          <ref-list id="bhd.Published_GuidelinesConsensus_Statem.reflist0">
            <ref id="bhd.REF1">
              <mixed-citation publication-type="web">American Society of Clinical Oncology. Policy statement update: genetic testing for cancer susceptibility. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://jco.ascopubs.org/cgi/content/full/21/12/2397">online</ext-link>. 2003. Accessed 6-5-17.</mixed-citation>
            </ref>
            <ref id="bhd.REF2">
              <mixed-citation publication-type="web">American Society of Clinical Oncology. Policy statement update: genetic testing for cancer susceptibility. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://jco.ascopubs.org/content/28/5/893.long">online</ext-link>; registration or institutional access required. 2010. Accessed 6-5-17.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="bhd.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="bhd.Literature_Cited.reflist0">
            <ref id="bhd.REF.american_society_of_clinical_oncology.2003.2397">
              <element-citation publication-type="journal">
                <person-group>
                  <collab>American Society of Clinical Oncology</collab>
                </person-group>
                <year>2003</year>
                <article-title>American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.</article-title>
                <source>J Clin Oncol</source>
                <volume>21</volume>
                <fpage>2397</fpage>
                <lpage>406</lpage>
                <pub-id pub-id-type="pmid">12692171</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.baba.2006.15552">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Baba</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hong</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sharma</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warren</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nickerson</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iwamatsu</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Esposito</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gillette</surname>
                    <given-names>WK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopkins</surname>
                    <given-names>RF</given-names>
                    <suffix>3rd</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Hartley</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Furihata</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oishi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhen</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burke</surname>
                    <given-names>TR</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Linehan</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zbar</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <article-title>Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling.</article-title>
                <source>Proc Natl Acad Sci USA.</source>
                <year>2006</year>
                <volume>103</volume>
                <fpage>15552</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17028174</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.chung.1996.365">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramos-Caro</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beers</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ford</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flowers</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Multiple lipomas, angiolipomas, and parathyroid adenomas in a patient with Birt-Hogg-Dube syndrome.</article-title>
                <source>Int J Dermatol.</source>
                <year>1996</year>
                <volume>35</volume>
                <fpage>365</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">8734663</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.claessens.2010.583">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Claessens</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weppler</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Geel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Creytens</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vreeburg</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wouters</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Steensel</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <article-title>Neuroendocrine carcinoma in a patient with Birt-Hogg-Dub&#x000e9; syndrome.</article-title>
                <source>Nat Rev Urol.</source>
                <year>2010</year>
                <volume>7</volume>
                <fpage>583</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">20842188</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.cocciolone.2010.1316">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cocciolone</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crotty</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haass</surname>
                    <given-names>NK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moloney</surname>
                    <given-names>FJ</given-names>
                  </name>
                </person-group>
                <article-title>Multiple desmoplastic melanomas in Birt-Hogg-Dub&#x000e9; syndrome and a proposed signaling link between folliculin, the mTOR pathway, and melanoma susceptibility.</article-title>
                <source>Arch Dermatol.</source>
                <year>2010</year>
                <volume>146</volume>
                <fpage>1316</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">21079084</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.da_silva.2003.820">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>da Silva</surname>
                    <given-names>NF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gentle</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hesson</surname>
                    <given-names>LB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morton</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Latif</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maher</surname>
                    <given-names>ER</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Analysis of the Birt-Hogg-Dub&#x000e9; (BHD) tumour suppressor gene in sporadic renal cell carcinoma and colorectal cancer.</article-title>
                <source>J Med Genet</source>
                <volume>40</volume>
                <fpage>820</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">14627671</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.daniel.2000.327">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Daniel</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teba</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Spontaneous pneumothorax and alpha 1-antitrypsin deficiency.</article-title>
                <source>Respir Care</source>
                <volume>45</volume>
                <fpage>327</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10771802</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.drummond.2002.301">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Drummond</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grigoris</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dutta</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Birt-Hogg-Dub&#x000e9; syndrome and multinodular goitre.</article-title>
                <source>Australas J Dermatol</source>
                <volume>43</volume>
                <fpage>301</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">12423440</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.flume.2005.720">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Flume</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strange</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ye</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ebeling</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hulsey</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clark</surname>
                    <given-names>LL</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Pneumothorax in cystic fibrosis.</article-title>
                <source>Chest</source>
                <volume>128</volume>
                <fpage>720</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16100160</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.fontcuberta.2011.143">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fontcuberta</surname>
                    <given-names>IC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salom&#x000e3;o</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quiram</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulido</surname>
                    <given-names>JS</given-names>
                  </name>
                </person-group>
                <article-title>Choroidal melanoma and lid fibrofoliculomas in Birt-Hogg-Dub&#x000e9; syndrome.</article-title>
                <source>Ophthalmic Genet.</source>
                <year>2011</year>
                <volume>32</volume>
                <fpage>143</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">21401403</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.gambichler.2000.856">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gambichler</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolter</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Altmeyer</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffman</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Treatment of Birt-Hogg-Dub&#x000e9; syndrome with erbium:YAG laser.</article-title>
                <source>J Am Acad Dermatol</source>
                <volume>43</volume>
                <fpage>856</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11050594</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.godbolt.2003.52">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Godbolt</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robertson</surname>
                    <given-names>IM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weedon</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Birt-Hogg-Dub&#x000e9; syndrome.</article-title>
                <source>Australas J Dermatol</source>
                <volume>44</volume>
                <fpage>52</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">12581083</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.graham.2005.39">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nolasco</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peterlin</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia</surname>
                    <given-names>CK</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Nonsense mutations in folliculin presenting as isolated familial spontaneous pneumothorax in adults.</article-title>
                <source>Am J Respir Crit Care Med</source>
                <volume>172</volume>
                <fpage>39</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">15805188</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.hasumi.2008.60">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hasumi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baba</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hong</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hasumi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yao</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valera</surname>
                    <given-names>VA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linehan</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>LS</given-names>
                  </name>
                </person-group>
                <article-title>Identification and characterization of a novel folliculin-interacting protein FNIP2.</article-title>
                <source>Gene.</source>
                <year>2008</year>
                <volume>415</volume>
                <fpage>60</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">18403135</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.jacob.2001.98">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jacob</surname>
                    <given-names>CI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dover</surname>
                    <given-names>JS</given-names>
                  </name>
                </person-group>
                <article-title>Birt-Hogg-Dube syndrome: treatment of cutaneous manifestations with laser skin resurfacing.</article-title>
                <source>Arch Dermatol.</source>
                <year>2001</year>
                <volume>137</volume>
                <fpage>98</fpage>
                <lpage>99</lpage>
                <pub-id pub-id-type="pmid">11176677</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.kahle.2001.43">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kahle</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hellwig</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulz</surname>
                    <given-names>T.</given-names>
                  </name>
                </person-group>
                <article-title>Multiple mantleomas in Birt-Hogg-Dub&#x000e9; syndrome: successful therapy with CO2 laser.</article-title>
                <source>Hautarzt.</source>
                <year>2001</year>
                <volume>52</volume>
                <fpage>43</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">11220238</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.kahnoski.2003.511">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kahnoski</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khoo</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nassif</surname>
                    <given-names>NT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lobo</surname>
                    <given-names>GP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Segelov</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teh</surname>
                    <given-names>BT</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Alterations of the Birt-Hogg-Dub&#x000e9; gene (BHD) in sporadic colorectal tumours.</article-title>
                <source>J Med Genet</source>
                <volume>40</volume>
                <fpage>511</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">12843323</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.khoo.2002.906">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Khoo</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giraud</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kahnoski</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Motorna</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nickolov</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Binet</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lambert</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferlicot</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolkenstein</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hammel</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bergerheim</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hedblad</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bradley</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teh</surname>
                    <given-names>BT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nordenskjold</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Clinical and genetic studies of Birt-Hogg-Dub&#x000e9; syndrome.</article-title>
                <source>J Med Genet</source>
                <volume>39</volume>
                <fpage>906</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">12471204</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.khoo.2003.4583">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Khoo</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kahnoski</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sugimura</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petillo</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shockley</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ludlow</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knapp</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giraud</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nordenskjold</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teh</surname>
                    <given-names>BT</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Inactivation of BHD in sporadic renal tumors.</article-title>
                <source>Cancer Res</source>
                <volume>63</volume>
                <fpage>4583</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12907635</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.klomp.2010.59">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Klomp</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petillo</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niemi</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dykema</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>XJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>S&#x000e4;&#x000e4;f</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zickert</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aly</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bergerheim</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nordenskj&#x000f6;ld</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gad</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giraud</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Denoux</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yonneau</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000e9;jean</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasiliu</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacKeigan</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teh</surname>
                    <given-names>BT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Furge</surname>
                    <given-names>KA</given-names>
                  </name>
                </person-group>
                <article-title>Birt-Hogg-Dub&#x000e9; renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression.</article-title>
                <source>BMC Med Genomics.</source>
                <year>2010</year>
                <volume>3</volume>
                <fpage>59</fpage>
                <pub-id pub-id-type="pmid">21162720</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.kluger.2010.527">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kluger</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giraud</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coupier</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Avril</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dereure</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guillot</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bessis</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Birt-Hogg-Dub&#x000e9; syndrome: clinical and genetic studies of 10 French families.</article-title>
                <source>Br J Dermatol.</source>
                <year>2010</year>
                <volume>162</volume>
                <fpage>527</fpage>
                <lpage>37</lpage>
                <pub-id pub-id-type="pmid">19785621</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.kumasaka.2014.100">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kumasaka</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitani</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kataoka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kikkawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tobino</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gunji</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kunogi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurihara</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seyama</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Characterization of pulmonary cysts in Birt-Hogg-Dub&#x000e9; syndrome: histopathological and morphometric analysis of 229 pulmonary cysts from 50 unrelated patients.</article-title>
                <source>Histopathology.</source>
                <year>2014</year>
                <volume>65</volume>
                <fpage>100</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">24393238</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.kunogi.2010.281">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kunogi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurihara</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikegami</surname>
                    <given-names>TS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shindo</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumasaka</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gunji</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kikkawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iwakami</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hino</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seyama</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Clinical and genetic spectrum of Birt&#x02013;Hogg&#x02013;Dub&#x000e9; syndrome patients in whom pneumothorax and/or multiple lung cysts are the presenting feature</article-title>
                <source>J Med Genet.</source>
                <year>2010</year>
                <volume>47</volume>
                <fpage>281</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">20413710</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.lindor.2001.653">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lindor</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hand</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burch</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>LE</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Birt-Hogg-Dube syndrome: an autosomal dominant disorder with predisposition to cancers of the kidney, fibrofolliculomas, and focal cutaneous mucinosis.</article-title>
                <source>Int J Dermatol.</source>
                <year>2001</year>
                <volume>40</volume>
                <fpage>653</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">11737429</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.lindor.2012.13">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lindor</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kasperbauer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewis</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pittelkow</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Birt-Hogg-Dube syndrome presenting as multiple oncocytic parotid tumors.</article-title>
                <source>Hered Cancer Clin Pract.</source>
                <year>2012</year>
                <volume>10</volume>
                <fpage>13</fpage>
                <pub-id pub-id-type="pmid">23050938</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.linehan.2005.2">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Linehan</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grubb</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coleman</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zbar</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walther</surname>
                    <given-names>MM</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>The genetic basis of cancer of kidney cancer: implications for gene-specific clinical management.</article-title>
                <source>BJU Int</source>
                <volume>95</volume>
                <supplement>Suppl 2</supplement>
                <fpage>2</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15720328</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.liu.2000.1120">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kwan</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Page</surname>
                    <given-names>EH</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Parotid oncocytoma in the Birt-Hogg-Dub&#x000e9; syndrome.</article-title>
                <source>J Am Acad Dermatol</source>
                <volume>43</volume>
                <fpage>1120</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">11100034</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.maff_.2011.345">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Maff&#x000e9;</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toschi</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Circo</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giachino</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giglio</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rizzo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carloni</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poletti</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomassetti</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ginardi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ungari</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Genuardi</surname>
                    <given-names>M.</given-names>
                  </name>
                </person-group>
                <article-title>Constitutional FLCN mutations in patients with suspected Birt-Hogg-Dub&#x000e9; syndrome ascertained for non-cutaneous manifestations.</article-title>
                <source>Clin Genet.</source>
                <year>2011</year>
                <volume>79</volume>
                <fpage>345</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">20618353</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.mendez.2004.1028">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mendez</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nadrous</surname>
                    <given-names>HF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vassallo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Decker</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ryu</surname>
                    <given-names>JH</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Pneumothorax in pulmonary Langerhans cell histiocytosis.</article-title>
                <source>Chest</source>
                <volume>125</volume>
                <fpage>1028</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">15006964</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.moore.2005.240">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>LE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>RT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campleman</surname>
                    <given-names>SL</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Lifestyle factors, exposures, genetic susceptibility, and renal cell cancer risk: a review.</article-title>
                <source>Cancer Invest</source>
                <volume>23</volume>
                <fpage>240</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">15945510</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.motaburgos.2013.323">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mota-Burgos</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Acosta</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000e1;rquez</surname>
                    <given-names>FV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mendiola</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herrera-Ceballos</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>Birt-Hogg-Dub&#x000e9; syndrome in a patient with melanoma and a novel mutation in the FCLN gene.</article-title>
                <source>Int J Dermatol.</source>
                <year>2013</year>
                <volume>52</volume>
                <fpage>323</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">23414156</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.nadershahi.1997.496">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nadershahi</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wescott</surname>
                    <given-names>WB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Egbert</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Birt-Hogg-Dub&#x000e9; syndrome: a review and presentation of the first case with oral lesions.</article-title>
                <source>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</source>
                <volume>83</volume>
                <fpage>496</fpage>
                <lpage>500</lpage>
                <pub-id pub-id-type="pmid">9127384</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.nahorski.2010.385">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nahorski</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lim</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gille</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKay</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rehal</surname>
                    <given-names>PK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ploeger</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Steensel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomlinson</surname>
                    <given-names>IP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Latif</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Menko</surname>
                    <given-names>FH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maher</surname>
                    <given-names>ER</given-names>
                  </name>
                </person-group>
                <article-title>Investigation of the Birt-Hogg-Dube tumour suppressor gene (FLCN) in familial and sporadic colorectal cancer.</article-title>
                <source>J Med Genet.</source>
                <year>2010</year>
                <volume>47</volume>
                <fpage>385</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">20522427</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.nickerson.2002.157">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nickerson</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warren</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toro</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matrosova</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glenn</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duray</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merino</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choyke</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pavlovich</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sharma</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walther</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munroe</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hill</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maher</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenberg</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerman</surname>
                    <given-names>MI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linehan</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zbar</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>LS</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dub&#x000e9; syndrome.</article-title>
                <source>Cancer Cell</source>
                <volume>2</volume>
                <fpage>157</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">12204536</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.painter.2005.522">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Painter</surname>
                    <given-names>JN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tapanainen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Somer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tukiainen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aittomaki</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>A 4-bp deletion in the Birt-Hogg-Dub&#x000e9; gene (FLCN) causes dominantly inherited spontaneous pneumothorax.</article-title>
                <source>Am J Hum Genet</source>
                <volume>76</volume>
                <fpage>522</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15657874</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.palmirotta.2008.382">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Palmirotta</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donati</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savonarola</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cota</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferroni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guadagni</surname>
                    <given-names>F.</given-names>
                  </name>
                </person-group>
                <article-title>Birt-Hogg-Dub&#x000e9; (BHD) syndrome: report of two novel germline mutations in the folliculin (FLCN) gene.</article-title>
                <source>Eur J Dermatol.</source>
                <year>2008</year>
                <volume>18</volume>
                <fpage>382</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">18573707</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.pavlovich.2005.1482">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pavlovich</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grubb</surname>
                    <given-names>RL</given-names>
                    <suffix>3rd</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Hurley</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glenn</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toro</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torres-Cabala</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merino</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zbar</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choyke</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walther</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linehan</surname>
                    <given-names>WM</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Evaluation and management of renal tumors in the Birt-Hogg-Dub&#x000e9; syndrome.</article-title>
                <source>J Urol</source>
                <volume>173</volume>
                <fpage>1482</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15821464</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.renfree.2012.792">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Renfree</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lawless</surname>
                    <given-names>KL</given-names>
                  </name>
                </person-group>
                <article-title>Multiple neurilemmomas in Birt-Hogg-Dub&#x000e9; syndrome: case report.</article-title>
                <source>J Hand Surg Am.</source>
                <year>2012</year>
                <volume>37</volume>
                <fpage>792</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">22326190</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.schmidt.2005.1023">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nickerson</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warren</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glenn</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toro</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merino</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choyke</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sharma</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peterson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morrison</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maher</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walther</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zbar</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linehan</surname>
                    <given-names>WM</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dub&#x000e9; syndrome.</article-title>
                <source>Am J Hum Genet</source>
                <volume>76</volume>
                <fpage>1023</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">15852235</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.schulz.1999.55">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schulz</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hartschuh</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Birt-Hogg-Dub&#x000e9; syndrome and Hornstein-Knickenberg syndrome are the same. Different sectioning technique as the cause of different histology.</article-title>
                <source>J Cutan Pathol</source>
                <volume>26</volume>
                <fpage>55</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">10189247</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.sempau.2010.637">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sempau</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruiz</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonz&#x000e1;lez-Mor&#x000e1;n</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Susanna</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hansen</surname>
                    <given-names>TV</given-names>
                  </name>
                </person-group>
                <article-title>New mutation in the Birt Hogg Dube gene.</article-title>
                <source>Actas Dermosifiliogr.</source>
                <year>2010</year>
                <volume>101</volume>
                <fpage>637</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">20858390</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.shin.2003.364">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shin</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shin</surname>
                    <given-names>YK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ku</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeong</surname>
                    <given-names>SY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hong</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>SY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>JG</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Mutations of the Birt-Hogg-Dub&#x000e9; (BHD) gene in sporadic colorectal carcinomas and colorectal carcinoma cell lines with microsatellite instability.</article-title>
                <source>J Med Genet</source>
                <volume>40</volume>
                <fpage>364</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12746401</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.stamatakis.2013.397">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stamatakis</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Metwalli</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Middelton</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marston Linehan</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <article-title>Diagnosis and management of BHD-associated kidney cancer.</article-title>
                <source>Fam Cancer.</source>
                <year>2013</year>
                <volume>12</volume>
                <fpage>397</fpage>
                <lpage>402</lpage>
                <pub-id pub-id-type="pmid">23703644</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.takagi.2008.5339">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Takagi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shiono</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piao</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abe</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hagiwara</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hino</surname>
                    <given-names>O.</given-names>
                  </name>
                </person-group>
                <article-title>Interaction of folliculin (Birt-Hogg-Dube gene product) with a novel Fnip1-like (FnipL/Fnip2) protein.</article-title>
                <source>Oncogene.</source>
                <year>2008</year>
                <volume>27</volume>
                <fpage>5339</fpage>
                <lpage>47</lpage>
                <pub-id pub-id-type="pmid">18663353</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.toro.1999.1195">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Toro</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glenn</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duray</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darling</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weirich</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zbar</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linehan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>ML</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Birt-Hogg-Dub&#x000e9; syndrome: a novel marker of kidney neoplasia.</article-title>
                <source>Arch Dermatol</source>
                <volume>135</volume>
                <fpage>1195</fpage>
                <lpage>202</lpage>
                <pub-id pub-id-type="pmid">10522666</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.toro.2007.1044">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Toro</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pautler</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stewart</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glenn</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weinreich</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toure</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wei</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zbar</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choyke</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinberg</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nguyen</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linehan</surname>
                    <given-names>WM</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Lung cysts, spontaneous pneumothorax, and genetic associations in 89 families with Birt-Hogg-Dub&#x000e9; syndrome.</article-title>
                <source>Am J Respir Crit Care Med</source>
                <volume>175</volume>
                <fpage>1044</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">17322109</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.toro.2008.321">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Toro</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wei</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glenn</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weinreich</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toure</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vocke</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choyke</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merino</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinto</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinberg</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linehan</surname>
                    <given-names>WM</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dub&#x000e9; syndrome: a new series of 50 families and a review of published reports.</article-title>
                <source>J Med Genet</source>
                <volume>45</volume>
                <fpage>321</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">18234728</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.vincent.2003.717">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farley</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>James</surname>
                    <given-names>WD</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Birt-Hogg-Dub&#x000e9; syndrome: two patients with neural tissue tumors.</article-title>
                <source>J Am Acad Dermatol</source>
                <volume>49</volume>
                <fpage>717</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">14512924</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.vocke.2005.931">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vocke</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pavlovich</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nickerson</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torres-Cabala</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merino</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walther</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zbar</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linehan</surname>
                    <given-names>WM</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dub&#x000e9;-associated renal tumors.</article-title>
                <source>J Natl Cancer Inst</source>
                <volume>97</volume>
                <fpage>931</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15956655</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.walter.1997.359">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirchhof</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korge</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heimann</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Flecked chorioretinopathy associated with Birt-Hogg-Dub&#x000e9; syndrome.</article-title>
                <source>Graefes Arch Clin Exp Ophthalmol</source>
                <volume>235</volume>
                <fpage>359</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">9202964</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.warren.2004.998">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Warren</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torres-Cabala</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merino</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matrosova</surname>
                    <given-names>VY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nickerson</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ma</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linehan</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zbar</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>LS</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Expression of Birt-Hogg-Dub&#x000e9; gene mRNA in normal and neoplastic human tissues.</article-title>
                <source>Mod Pathol</source>
                <volume>17</volume>
                <fpage>998</fpage>
                <lpage>1011</lpage>
                <pub-id pub-id-type="pmid">15143337</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.welsch.2005.668">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Welsch</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krunic</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Medenica</surname>
                    <given-names>MM</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Birt-Hogg-Dub&#x000e9; Syndrome.</article-title>
                <source>Int J Dermatol</source>
                <volume>44</volume>
                <fpage>668</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">16101870</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.yan.2014.2640">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gingras</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dunlop</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nou&#x000eb;t</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dupuy</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jalali</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Possik</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coull</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kharitidi</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dydensborg</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faubert</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamps</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sabourin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Preston</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davies</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roughead</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chotard</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Steensel</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tee</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pause</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>The tumor suppressor folliculin regulates AMPK-dependent metabolic transformation.</article-title>
                <source>J Clin Invest.</source>
                <year>2014</year>
                <volume>124</volume>
                <fpage>2640</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">24762438</pub-id>
              </element-citation>
            </ref>
            <ref id="bhd.REF.zbar.2002.393">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zbar</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alvord</surname>
                    <given-names>WG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glenn</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pavlovich</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walther</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choyke</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weirich</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hewitt</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duray</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gabril</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenberg</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merino</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toro</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linehan</surname>
                    <given-names>WM</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dub&#x000e9; syndrome.</article-title>
                <source>Cancer Epidemiol Biomarkers Prev</source>
                <volume>11</volume>
                <fpage>393</fpage>
                <lpage>400</lpage>
                <pub-id pub-id-type="pmid">11927500</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="bhd.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="bhd.Suggested_Reading.reflist0">
            <ref id="bhd.REF.schmidt">
              <mixed-citation publication-type="web">Schmidt LS. The Birt-Hogg-Dub&#x000e9; syndrome. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G, eds. <italic toggle="yes">The Online Metabolic and Molecular Bases of Inherited Disease</italic> (<italic toggle="yes">OMMBID</italic>). Chap 41.1. McGraw-Hill. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://ommbid.mhmedical.com/">online</ext-link>. Accessed 6-5-17.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="bhd.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="bhd.Author_History">
          <title>Author History</title>
          <p>Manop Pithukpakorn, MD; Mahidol University (2006-2008)Jorge R Toro, MD (2006-present)</p>
        </sec>
        <sec id="bhd.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>7 August 2014 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>9 September 2008 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>27 February 2006 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>30 November 2005 (jt) Original submission</p>
            </list-item>
          </list>
          <p>Note: Pursuant to 17 USC Section 105 of the United States Copyright Act, the <italic toggle="yes">GeneReview</italic> &#x02018;Birt-Hogg-Dub&#x000e9; Syndrome&#x02019; is in the public domain in the United States of America.</p>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
